David Murdock, MD
Cardiovascular Disease · Wausau, WINPI 1942200910
Payments from drug & device makers
Across 255 payments — averaging $5352.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$871K
- Amgen$303K
- Boehringer Ingelheim$111K
- Lilly USA, LLC$42K
- Amryt Pharma Holdings Ltd$16K
- Regeneron$10K
- plus $12K from 19 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 18 | $870,602 |
| Amgen | 35 | $303,142 |
| Boehringer Ingelheim | 91 | $110,665 |
| Lilly USA, LLC | 37 | $42,461 |
| Amryt Pharma Holdings Ltd | 12 | $15,540 |
| Regeneron | 14 | $10,399 |
| E.r. Squibb & Sons, L.L.C. | 3 | $5,216 |
| Esperion Therapeutics, Inc. | 1 | $1,500 |
| Chiesi USA, Inc. | 1 | $1,404 |
| Aegerion Pharmaceuticals, Inc. | 1 | $1,000 |
| Novo Nordisk | 14 | $380 |
| Boehringer Ingelheim France S.a.s. | 3 | $359 |
| AstraZeneca | 5 | $351 |
| Bayer | 3 | $250 |
| Pfizer | 2 | $227 |
| Johnson & Johnson | 4 | $208 |
| Regeneron Healthcare Solutions, Inc. | 2 | $204 |
| Medtronic | 1 | $180 |
| Actelion Pharmaceuticals US, Inc. | 1 | $125 |
| United Therapeutics Corporation | 1 | $125 |
| Abbott | 1 | $116 |
| Inari Medical, Inc. | 1 | $98 |
| Boston Scientific | 1 | $89 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $80 |
| Janssen Scientific Affairs, LLC | 1 | $67 |
How this compares
$1,364,788 in reported general payments places this provider in the 95th percentile of 322 cardiovascular disease providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Wausau
- Timothy LogemannWausau$749K
- Bryan AustinWausau$35K
- Ameer KabourAppleton$1.1M
- Eric RobertsMilwaukee$982K
- Paul HinderakerMadison$463K
- David PhamMadison$425K
- James RiderGreen Bay$389K
- Subhashish AgarwalBrookfield$378K
- Farhan RazaMadison$359K
- Renuka JainMilwaukee$340K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.